![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig3_HTML.png)
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
![Improved early detection of ovarian cancer using longitudinal multimarker models | British Journal of Cancer Improved early detection of ovarian cancer using longitudinal multimarker models | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-019-0718-9/MediaObjects/41416_2019_718_Fig1_HTML.png)
Improved early detection of ovarian cancer using longitudinal multimarker models | British Journal of Cancer
![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig1_HTML.png)
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study | PLOS Medicine
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure1.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![Proposed reference value of the CA 125 tumour marker in men. Potential applications in clinical practice - ScienceDirect Proposed reference value of the CA 125 tumour marker in men. Potential applications in clinical practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009912008001161-gr1.jpg)